COVID-19: Vaccines and Therapeutics

Feb 14, 2022
During the omicron wave, the Pfizer or Moderna COVID-19 vaccine was 87% effective at preventing emergency and urgent care visits and 95% effective at preventing hospitalizations in adults who received a third dose in the prior two months, according to a study released by the Centers for Disease…
Feb 11, 2022
Pfizer will delay asking the Food and Drug Administration to authorize its COVID-19 vaccine for children under age 5 until it has clinical trial data on a third dose in this age group, which it expects in early April.
Feb 11, 2022
As the state with the highest percentage of its population vaccinated, Vermont continues to urge that children become vaccinated and everyone receive a booster.
Feb 9, 2022
As rural health care leaders from the AHA and other health care organizations convened at AHA’s Rural Health Care Leadership Conference this week, a robust discussion took place over the role hospital and health system trustees can play in building confidence in the COVID-19 vaccines in their rural…
Feb 7, 2022
On a recent AHA webinar with the Centers for Disease Control and Prevention, health care leaders discussed key strategies for building among pregnant people trust in the safety and efficacy of COVID-19 vaccines.
Feb 7, 2022
The Centers for Disease Control and Prevention Friday endorsed the Food and Drug Ad
Feb 7, 2022
On a recent AHA webinar, health care leaders discussed key strategies for building trust in the safety and efficacy of the COVID1-9 vaccines among pregnant people.
Feb 4, 2022
Three leading Indiana health systems join forces to urge people in their communities to get the COVID-19 vaccine and do their part to fight COVID-19.
Feb 4, 2022
Now that children are eligible for the COVID-19 vaccine, families are considering how to best keep their children safe and healthy. In this new podcast series, Joining Hands to Build Pediatric COVID-19 Vaccine Confidence, we are speaking with leaders from three national organizations to discuss how…
Feb 3, 2022
The White House today released a preliminary planning guide to inform jurisdictional, federal partner and pharmacy planning to distribute the Pfizer COVID-19 vaccine for children aged 6 months through 4 should the Food and Drug Administration authorize the vaccine for emergency use in this age…